Nicotinamide in Hemodialysis Patients With Hyperphosphatemia

计划入组 252 人 · 首次发布于 2010 年 9 月 14 日

Hyperphosphatemia in Children With Chronic Kidney Disease

计划入组 40 人 · 首次发布于 2017 年 6 月 28 日

Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia

计划入组 45 人 · 首次发布于 2016 年 7 月 18 日

Sevelamer(Renagel, Renvela, Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva))

C₆H₁₂ClNO · Rx

Ferric oxyhydroxide

FeHO₂

cFGF23 gene therapy (AAV, X-linked hypophosphatemia)

China Approves First-in-Class Tenapanor for Hyperphosphatemia in Dialysis Patients

Unicycive Therapeutics Resubmits NDA for Novel Phosphate Binder Targeting Hyperphosphatemia in Dialysis Patients

Alebund's AP301 Meets Primary Endpoint in Phase 3 Trial for Hyperphosphatemia in Dialysis Patients